![](https://www.diabetesnews.com/wp-content/uploads/2014/03/FDA_publicdomain2_6-150x150.jpg)
The FDA has approved 2 additional doses of Eli Lilly’s Trulicity (dulaglutide) for treating type 2 diabetes. The approval of the new 3.0 mg and 4.5 mg doses of dulaglutide was based on clinical trial results showing benefits for A1C levels and weight loss. Read more